Angiopoietin 1 (ANGPT1) Antibody

Este producto es parte de ANGPT - Angiopoietin
Product Graph
273€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Angiopoietin 1 (ANGPT1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx101429
tested applications
WB, IHC, IF/ICC

Description

Polyclonal Antibody to Angiopoietin 1 (ANGPT1).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetAngiopoietin 1 (ANGPT1)
HostRabbit
ReactivityRat
Recommended DilutionWB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
PurificationPurified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography.
Size 1100 µl
Size 2200 µl
Size 31 ml
FormLiquid
Tested ApplicationsWB, IHC, IF/ICC
Buffer0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
AvailabilityShipped within 5-7 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDO35460
AliasAGP1,AGPT,ANG1,HAE5,AGPT-1
BackgroundAntibody anti-ANGPT1
StatusRUO
NoteConcentration: 0.27 mg/ml -

Descripción

ANGPT1 is a secreted glycoprotein that plays a critical role in angiogenesis, the process of new blood vessel formation, and the stabilization of vascular networks. ANGPT1 binds to and activates the Tie2 receptor, a tyrosine kinase expressed on endothelial cells, leading to signaling pathways that promote endothelial cell survival, migration, and the formation of stable, mature blood vessels. ANGPT1 is essential for maintaining vascular integrity and preventing vascular leakage by enhancing cell-cell junctions and stabilizing endothelial barriers. It also counteracts pro-inflammatory signals and prevents excessive vascular permeability caused by VEGF or other stressors. ANGPT1 is involved in developmental processes such as embryonic vascular formation and tissue regeneration. Dysregulation of ANGPT1 has been implicated in vascular disorders, including chronic inflammation, edema, and cardiovascular diseases. ANGPT1’s role in maintaining vascular stability makes it a therapeutic target for diseases involving abnormal angiogenesis, such as cancer, diabetic retinopathy, and sepsis.

Related Products

EH0035

Human ANG1(Angiopoietin-1) ELISA Kit

Ver Producto
EM0016

Mouse Ang1(Angiopoietin-1) ELISA Kit

Ver Producto
EP0202

Porcine ANG1(Angiopoietin-1) ELISA Kit

Ver Producto